At a glance
- Originator Bristol-Myers Squibb
- Class Anti-inflammatories; Antipsoriatics; Naphthalenes; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Phospholipase A2 inhibitors; Prostaglandin synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atopic dermatitis; Psoriasis